Analyst firms · Morgan Stanley · PODD

Morgan Stanley PODD price target and rating history

Insulet Corporation (PODD) · Health Care

Morgan Stanley rates Insulet Corporation (PODD) Overweight with a $234 price target, as of its latest action on Dec 4, 2023. It has published 5 rating actions on PODD since November 2021, including 1 upgrade and 0 downgrades. Across 10 firms with a PODD price target in the last 12 months, the median target is $182.

Current rating
Overweight
Price target
$234
Median target, all firms
$182
Actions on PODD
5

Morgan Stanley price target on PODD

$343$289$23420222023202420252026
Morgan Stanley price target on PODD, each point a stated target, November 2021 to December 2023.

Every Morgan Stanley rating on PODD

How other firms rate PODD

Each firm's latest rating and stated target in the last 12 months.

FirmRatingPrice targetDate
BarclaysEqual Weight$150Oct 7, 2026
Truist SecuritiesHold$153Aug 6, 2026
Wells FargoEqual Weight$144Aug 6, 2026
BTIGNeutralAug 6, 2026
Leerink PartnersMarket Perform$145Aug 6, 2026
OppenheimerPerformAug 5, 2026
UBSNeutral$174Jul 28, 2026
Deutsche BankBuy$190Jun 23, 2026
William BlairOutperformMay 20, 2026
Rothschild & Co RedburnNeutral$220Apr 24, 2026
CitigroupNeutral$230Apr 7, 2026
TD CowenHold$294Jan 27, 2026
Evercore ISIOutperform$370Dec 16, 2025

Questions about Morgan Stanley and PODD

What is Morgan Stanley's price target for PODD?
Morgan Stanley's latest stated price target for Insulet Corporation (PODD) is $234, from its action on Dec 4, 2023.
What is Morgan Stanley's rating on PODD?
Morgan Stanley rates PODD Overweight, a bullish rating, as of Dec 4, 2023.
When did Morgan Stanley last change its view on PODD?
On Dec 4, 2023, Morgan Stanley upgrades to Overweight from Equal-Weight, price target $185 to $234.
How does Morgan Stanley's PODD target compare with other analysts?
Across 10 firms with a PODD price target in the last 12 months, the median target is $182.

More PODD rating histories

All Morgan Stanley ratingsPODD news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.